Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study Mikkel AndreassenJens FaberLars Østergaard Kristensen OriginalPaper 21 August 2010 Pages: 1 - 10
Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression Ilan ShimonCarlos BenbassatSimona Grozinsky-Glasberg OriginalPaper 18 August 2010 Pages: 11 - 15
Azathioprine as an alternative treatment in primary hypophysitis L. PapanastasiouT. PappaG. Piaditis OriginalPaper 31 August 2010 Pages: 16 - 22
Demographic differences in incidence for pituitary adenoma Bradley D. McDowellRobert B. WallaceJanet A. Schlechte OriginalPaper 01 September 2010 Pages: 23 - 30
Comparison of three methods for the estimation of the pituitary gland volume using magnetic resonance imaging: a stereological study Tolga ErtekinNiyazi AcerMehmet Turgut OriginalPaper 31 August 2010 Pages: 31 - 38
Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine Bashir Ahmad LawayShahnaz Ahmad MirAbdul Hamid Zargar OriginalPaper 27 August 2010 Pages: 39 - 43
Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia David L. KleinbergPietro AmeriBaljit Singh OriginalPaper 02 October 2010 Pages: 44 - 52
On the shoulders of giants: Harvey Cushing’s experience with acromegaly and gigantism at the Johns Hopkins Hospital, 1896–1912 Courtney PendletonHadie AdamsAlfredo Quiñones-Hinojosa OriginalPaper 07 September 2010 Pages: 53 - 60
Children with Cushing’s syndrome: primary pigmented nodular adrenocortical disease should always be suspected Renata Marques Gonçalves da SilvaEmília PintoJulio Abucham OriginalPaper 06 October 2010 Pages: 61 - 67
Effect of dopaminergic drug treatment on surgical findings in prolactinomas Maria MenucciAlfredo Quiñones-HinojosaRoberto Salvatori OriginalPaper 28 September 2010 Pages: 68 - 74
Is left ventricular dysfunction reversed after treatment of active acromegaly? Savvas T. H. ToumanidisMaria Eleftheria EvangelopoulosMaria Alevizaki OriginalPaper 21 October 2010 Pages: 75 - 79
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy Troy H. DillardS. Humayun GultekinMaria Fleseriu OriginalPaper 24 October 2010 Pages: 80 - 91
Atypical pituitary adenoma with malignant features Adam N. MamelakJohn D. CarmichaelH. Vivien Bonert Case Report 24 October 2008 Pages: 92 - 97